Medical Health & Life Science Research News

Antinuclear antibody test market to hit 12.4% CAGR and projected to reach US$ 1,476.1 million by 2021 according to new research report

Medical Market Research

The global antinuclear antibody (ANA) testing market expected to reach USD 1,476.1 million by 2021 from USD 823.5 million in 2016, at a CAGR of 12.4%. Assay kits & reagents segment is expected to register highest growth rate in ANA testing market, byproduct, during forecast period. Study report aims to provide insights into global antinuclear antibody test market.

- Advertising -

Download Study Papers on Antinuclear Antibody Test Market spread across 166 Pages, Profiling 10 Companies and supported with 73 Tables and 103 Figures is now available at…mple?rname=696521 .

The antinuclear antibody test market is segmented into five major disease segments, namely, rheumatoid arthritis, systemic lupus erythematosus, Sjögren’s syndrome, scleroderma, and other diseases. Other diseases include Raynaud’s Syndrome, polymyositis, mixed connective tissue disease, drug-induced lupus, and autoimmune hepatitis.

The rheumatoid arthritis segment is expected to account for the largest market share, primarily due to the increasing incidence of rheumatoid arthritis.

- Advertising -

Target Audience for this Report:

  • ANA Testing Instrument Manufacturers and Suppliers
  • Clinical Laboratories
  • Hospitals
  • Pharmaceutical and Biotechnology Companies
  • Academic Research Institutes Related to Antinuclear Antibody Testing

The global antinuclear antibody test market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America will continue to dominate the global market in the forecast period.

However, Asia is expected to witness the highest growth in the coming years, with the growth in this regional segment centered at China, Japan, and India.

Report at .

The high growth in this segment is attributed to the growing number of reagent rental agreements and increasing prevalence of autoimmune diseases worldwide. Details on regional markets for these segments are also presented in this report.

leading players are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

Competitive Landscape

1 Introduction

2 Strategic Overview

3 Market Share Analysis

4 Competitive Situation and Trends

5 New Product Launches

6 Other Developments

Key developments in antinuclear antibody test market with trends. Top players in antinuclear antibody test market players are Alere Inc.

(U.S.), Bio-Rad Laboratories, Inc. (U.S.), ERBA Diagnostics, Inc. (U.S.), Trinity Biotech plc (Ireland), Thermo Fisher Scientific, Inc.

(U.S.), Antibodies, Inc. (U.S.), EUROIMMUN AG (Germany), Immuno Concepts (U.S.), Inova Diagnostics (U.S.), and Zeus Scientific, Inc. (U.S.).

Report: .

North America largest regional segment in global ANA testing market, followed by Europe, Asia, & Rest of the World (RoW). Growth in North American market primarily driven by rising geriatric population & growing number of people covered under medical insurance in U.S.

To forecast size of market segments with respect to four main regions, namely, North America, Europe, Asia, & Rest of the World (RoW).

The above mentioned market research data, current market size, and forecast of future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach and levels of output in order to remain successful in the ANA testing market.

News From

RnR Market Research - Market Research and Competitive Analysis ReportsRnR Market Research
Category: Market Research Publishers and RetailersCompany about: is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
This email address is being protected from spambots. You need JavaScript enabled to view it.